EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma in treating early T cell precursors-lymphoblastic lymphoma in pediatric patients

Huang Zhizhuo, Jin Ling, Liu Wei, Sun Lirong, Zhang Baoxi, Zhuang Shuquan, Yuan Xiaojun, Jia Yueping, Zhang Yonghong

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2025.101084 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Huang Zhizhuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To analyze the clinical features of early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in pediatric patients and to summarize the efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma (CNCL) Non-Hodgkin Lymphoma (NHL) 2017-LBL for ETP-LBL.

Methods

Clinical data of 19 children with ETP-LBL admitted to CNCL from May 2017 to August 2023 were retrospectively collected.

Results

The median age of onset was 10 years (4.5-13 years), including 16 males (84.2 %). All patients were in stage IV and were treated with high-risk chemotherapy regimen. 11 of them (57.9 %) underwent hematopoietic stem cell transplantation (HSCT). The proportion of leukemia stage in the HSCT group was significantly higher than that in the chemotherapy group (72.7 % vs. 25.0 %), and the central nervous system (CNS) status was CNS2/3 in the HSCT group (100 % vs. 50 %).The 3-year overall survival (OS) and event free survival (EFS) were (93.8 ± 0.61) % and (88.2 ± 0.78) %, respectively.

Conclusion

Over 50 % of pediatric ETP-LBL patients received HSCT, with their long-term survival rates comparable to the chemotherapy group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationHumansChildMaleChild, PreschoolAdolescentFemaleChinaRetrospective Studies

Stichwörter der Autor:innen

ChemotherapyEarly T cell precursors-lymphoblastic lymphomaHematopoietic stem cell transplantation, prognosisPediatric patientsPrognosis

Autor:innen und Institutionen

  • Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China.
  • Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Ch…
  • Department of Hematology & Oncology, Zhengzhou Children's Hospital, Zhengzhou 450018, China.
  • Department of Pediatric Hematology & Oncology, the Affiliated Hospital of Qingdao University, Qingdao 266003, China.
  • Department of Pediatrics, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China.
  • Department of Pediatrics, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou 362002, China.

Zitieren

APA

Zhizhuo, H., Ling, J., Wei, L., Lirong, S., Baoxi, Z., Shuquan, Z., Xiaojun, Y., Yueping, J., & Yonghong, Z. (2026). Efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma in treating early T cell precursors-lymphoblastic lymphoma in pediatric patients. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101084

Vancouver

Zhizhuo H, Ling J, Wei L, Lirong S, Baoxi Z, Shuquan Z, et al. Efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma in treating early T cell precursors-lymphoblastic lymphoma in pediatric patients. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2025.101084

BibTeX
@article{Zhizhuo2026,
  author = {Zhizhuo, Huang and Ling, Jin and Wei, Liu and Lirong, Sun and Baoxi, Zhang and Shuquan, Zhuang and Xiaojun, Yuan and Yueping, Jia and Yonghong, Zhang},
  title = {Efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma in treating early T cell precursors-lymphoblastic lymphoma in pediatric patients},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2025.101084}
}
Kostenlos starten →